Administration of a third dose of vaccine to the IBD group sometime after 12 weeks following the second dose caused plasmablasts to spike again to 180 cells per million total B cells and this burst contained cells that expressed IgG and IgA (Figure 3, C and D). This evidence concerns the gene CD79A and inflammatory bowel disease.